These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2783330)
1. Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease. Oseroff A; Krishnamurti C; Hassett A; Tang D; Alving B J Lab Clin Med; 1989 Jan; 113(1):88-93. PubMed ID: 2783330 [TBL] [Abstract][Full Text] [Related]
2. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction. Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044 [TBL] [Abstract][Full Text] [Related]
3. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity]. Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860 [TBL] [Abstract][Full Text] [Related]
4. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Siegbahn A; Ruusuvaara L Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043 [TBL] [Abstract][Full Text] [Related]
5. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system. Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812 [TBL] [Abstract][Full Text] [Related]
6. A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosis. Huber K; Jörg M; Probst P; Schuster E; Lang I; Kaindl F; Binder BR Thromb Haemost; 1992 Feb; 67(2):209-13. PubMed ID: 1621240 [TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor 1 is elevated in the children of men with premature myocardial infarction. Rallidis LS; Megalou AA; Papageorgakis NH; Trikas AG; Chatzidimitriou GI; Tsitouris GK Thromb Haemost; 1996 Sep; 76(3):417-21. PubMed ID: 8883280 [TBL] [Abstract][Full Text] [Related]
8. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors]. Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288 [TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery disease. Nikfardjam M; Graf S; Beckmann R; Hornykewycz S; Koller-Strametz J; Binder BR; Huber K Thromb Haemost; 1999 Sep; 82 Suppl 1():80-4. PubMed ID: 10695493 [TBL] [Abstract][Full Text] [Related]
11. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis. Tran-Thang C; Fasel-Felley J; Pralong G; Hofstetter JR; Bachmann F; Kruithof EK Thromb Haemost; 1989 Sep; 62(2):651-3. PubMed ID: 2510345 [TBL] [Abstract][Full Text] [Related]
12. [Changes in tissue plasminogen activator and plasminogen activator inhibitor during administration of nitroglycerine into internal thoracic artery in dogs with acute myocardial ischemia]. Wu X; Wang CF; Sheng J; Zhu J Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):527-9. PubMed ID: 15355613 [TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states. Kruithof EK; Gudinchet A; Bachmann F Thromb Haemost; 1988 Feb; 59(1):7-12. PubMed ID: 3129809 [TBL] [Abstract][Full Text] [Related]
14. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease. Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597 [TBL] [Abstract][Full Text] [Related]
15. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. Hamsten A; Wiman B; de Faire U; Blombäck M N Engl J Med; 1985 Dec; 313(25):1557-63. PubMed ID: 3934538 [TBL] [Abstract][Full Text] [Related]
16. Levels of plasminogen activator inhibitor in patients with angina pectoris. Korninger C; Jäger R; Huber K; Lechner K Klin Wochenschr; 1988; 66 Suppl 12():59-61. PubMed ID: 3258044 [TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia. Sebestjen M; Zegura B; Guzic-Salobir B; Keber I Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies. Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431 [TBL] [Abstract][Full Text] [Related]
19. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1). Kluft C; Jie AF; Rijken DC; Verheijen JH Thromb Haemost; 1988 Apr; 59(2):329-32. PubMed ID: 3133814 [TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic activity in peripheral atherosclerosis in the elderly. van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]